154 related articles for article (PubMed ID: 35536092)
1. Triazole-resistant
Wang Q; Li Y; Li Y; Osherov N; Goldman GH; Verweij PE; Zheng B; Li R; Chen W; Liang T; Wan Z; Liu W
Emerg Microbes Infect; 2022 Dec; 11(1):1435-1438. PubMed ID: 35536092
[No Abstract] [Full Text] [Related]
2. Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.
Heo ST; Tatara AM; Jiménez-Ortigosa C; Jiang Y; Lewis RE; Tarrand J; Tverdek F; Albert ND; Verweij PE; Meis JF; Mikos AG; Perlin DS; Kontoyiannis DP
Clin Infect Dis; 2017 Jul; 65(2):216-225. PubMed ID: 28379304
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.
Gregson L; Goodwin J; Johnson A; McEntee L; Moore CB; Richardson M; Hope WW; Howard SJ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5778-80. PubMed ID: 24041890
[TBL] [Abstract][Full Text] [Related]
4. Emergence of W272C Substitution in Hmg1 in a Triazole-Resistant Isolate of Aspergillus fumigatus from a Chinese Patient with Chronic Cavitary Pulmonary Aspergillosis.
Liang T; Yang X; Li R; Yang E; Wang Q; Osherov N; Chen W; Wan Z; Liu W
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0026321. PubMed ID: 33941517
[TBL] [Abstract][Full Text] [Related]
5. Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations.
Atamna A; Yeshurun M; Shargian L; Raanani P; Kramer M; Ben Zvi H; Ben Ami R; Marr KA; Bishara J
J Antimicrob Chemother; 2024 May; 79(5):1191-1192. PubMed ID: 38334380
[No Abstract] [Full Text] [Related]
6. Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in
Rivero-Menendez O; Soto-Debran JC; Medina N; Lucio J; Mellado E; Alastruey-Izquierdo A
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285229
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE
J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488
[TBL] [Abstract][Full Text] [Related]
8. Triazole Resistance in
Zhang M; Feng CL; Chen F; He Q; Su X; Shi Y
Chin Med J (Engl); 2017 Mar; 130(6):665-668. PubMed ID: 28303848
[TBL] [Abstract][Full Text] [Related]
9. Clinical epidemiology of pulmonary aspergillosis in hospitalized patients and contribution of Cyp51A, Yap1, and Cdr1B mutations to voriconazole resistance in etiologic Aspergillus species.
Salehi Z; Sharifynia S; Jamzivar F; Shams-Ghahfarokhi M; Poorabdollah M; Abtahian Z; Nasiri N; Marjani M; Moniri A; Salehi M; Tabarsi P; Razzaghi-Abyaneh M
Eur J Clin Microbiol Infect Dis; 2023 Jul; 42(7):853-864. PubMed ID: 37142789
[TBL] [Abstract][Full Text] [Related]
10. Multi-triazole-resistant Aspergillus fumigatus infections in Australia.
Kidd SE; Goeman E; Meis JF; Slavin MA; Verweij PE
Mycoses; 2015 Jun; 58(6):350-5. PubMed ID: 25885568
[TBL] [Abstract][Full Text] [Related]
11. cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
Bader O; Weig M; Reichard U; Lugert R; Kuhns M; Christner M; Held J; Peter S; Schumacher U; Buchheidt D; Tintelnot K; Groß U;
Antimicrob Agents Chemother; 2013 Aug; 57(8):3513-7. PubMed ID: 23669382
[TBL] [Abstract][Full Text] [Related]
12.
Talbot JJ; Frisvad JC; Meis JF; Hagen F; Verweij PE; Hibbs DE; Lai F; Groundwater PW; Samson RA; Kidd SE; Barrs VR; Houbraken J
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451501
[TBL] [Abstract][Full Text] [Related]
13. Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms.
Garcia-Rubio R; Alcazar-Fuoli L; Monteiro MC; Monzon S; Cuesta I; Pelaez T; Mellado E
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632011
[TBL] [Abstract][Full Text] [Related]
14. Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
Buil JB; Brüggemann RJM; Wasmann RE; Zoll J; Meis JF; Melchers WJG; Mouton JW; Verweij PE
J Antimicrob Chemother; 2018 Jan; 73(1):134-142. PubMed ID: 29048485
[TBL] [Abstract][Full Text] [Related]
15. Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis.
Pelaez T; Gijón P; Bunsow E; Bouza E; Sánchez-Yebra W; Valerio M; Gama B; Cuenca-Estrella M; Mellado E
J Clin Microbiol; 2012 Jul; 50(7):2531-4. PubMed ID: 22573589
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
[TBL] [Abstract][Full Text] [Related]
17. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
[TBL] [Abstract][Full Text] [Related]
18. Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole.
Escribano P; Recio S; Peláez T; Bouza E; Guinea J
Antimicrob Agents Chemother; 2011 May; 55(5):2460-2. PubMed ID: 21321141
[TBL] [Abstract][Full Text] [Related]
19. Triazole Resistance Is Still Not Emerging in Aspergillus fumigatus Isolates Causing Invasive Aspergillosis in Brazilian Patients.
Negri CE; Gonçalves SS; Sousa ACP; Bergamasco MD; Martino MDV; Queiroz-Telles F; Aquino VR; Castro PTO; Hagen F; Meis JF; Colombo AL
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28893772
[No Abstract] [Full Text] [Related]
20. Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a
Rößler S; Bader O; Stölzel F; Sommer U; Spiess B; Geibel S; Buchheidt D; Groß U; Baretton G; Jacobs E; Ostrosky-Zeichner L
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28743702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
